Para 3 of DPCO 2013 invoked by NPPA

The national drug price regulator National Pharmaceutical Pricing Authority (NPPA) has invoked Para 3 of the DPCO (Drug Price Control Order)-2013 for ensuring the consistent supply of medicines and medical devices in the country.

According to para 3 of DPCO-2013, NPPA may give directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations with a view to achieve adequate availability or stock and to regulate the distribution of drugs and in case of emergency or in circumstances of urgency or in case of non-commercial use in public interest, direct any manufacturer of any active pharmaceutical ingredient or bulk drug or formulation to increase the production and to sell such active pharmaceutical ingredient or bulk drug to such other manufacturer(s) of formulations and to direct formulators to sell the formulations to institutions, hospitals or any agency as the case may be.

The notification said that, “In exercise of the powers conferred by sections 3 and 5 of the Essential Commodities Act, 1955 (10 of 1955), the Central Government hereby directs that National Pharmaceutical Pricing Authority, established vide Government of India in the Ministry of Chemicals and Fertilizers Resolution No. 33/7/97-PI-I dated the August 29, 1997, published in Part I, Section 1 of the Gazette of India, Extraordinary, shall also exercise the functions of the Central Government in respect of paragraph 3 of the Drugs Prices Control Order, 2013 in addition to the functions specified in the Orders of the Government of India, in the Ministry of Chemicals and Fertilizers number S.O. 1394 (E), dated the May 30, 2013 and S.O. 528(E), dated 15th February, 2016.”

Invoking of Para 3 of DPCO-2013 will assist the drug pricing regulator to resolve issues associated with the availability, supply and shortage of drugs and medical devices.

  • Related Posts

    • Health
    • February 10, 2024
    • 11 views
    Appointment of CEO packs a Punch in NeuroEqulibrium’s Global Goal

    New Delhi: The ambition of NeuroEquilibrium gets a shot in the arm with the appointment of industry vetran Samit Verma as its CEO (Chief Executive Officer). Its global aspiration will…

    Millets reigned Supreme in International Symposium on Gut Health

    New Delhi: Millets reign supreme as gut health assumes most important aspect of the latest preventive and curative healthcare approach. This fact was writ large on Symposium on ‘Gut Health…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down